| Principles and results of high-intensity focused ultrasound for localized prostate cancer. | |
| | |
MedLine Citation:
|
PMID: 15452554 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Focused ultrasound holds promise in a large number of therapeutic applications. It has long been known that high-intensity focused ultrasound (HIFU) can kill tissue through coagulative necrosis. However, it is only in recent years that practical clinical applications are becoming possible, with the development of high-power ultrasound arrays and noninvasive monitoring methods. In the last decade, HIFU have been adapted and used to treat localized prostate cancer and it is now commercially available in Europe. In this article, preclinical studies and clinical development of prostate HIFU as well as early clinical results from our center and international studies are reviewed. Early results demonstrated that prostate HIFU is efficient to obtain local control for low- and intermediate-risk localized prostate cancer; however, long-term follow-up is still needed to estimate the efficacy of prostate HIFU in terms of specific cancer mortality. This makes HIFU a viable alternative in patients not candidate for radical therapy. |
| | |
Authors:
|
M Colombel; A Gelet |
Related Documents
:
|
21428884 - Incorporation of targeted agents in the management of patients with advanced gastric ca... 16861124 - Chemotherapy for advanced prostate cancer: docetaxel and beyond. 21266974 - An inflammation-based prognostic score (mgps) predicts cancer survival independent of t... 19325494 - Current status of mri for the diagnosis, staging and prognosis of prostate cancer: impl... 19184474 - Lung cancer in chrysotile asbestos workers: analyses based on the two-stage clonal expa... 20939894 - Natural killer cells are crucial for the efficacy of icon (factor vii/human igg1 fc) im... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Prostate cancer and prostatic diseases Volume: 7 ISSN: 1365-7852 ISO Abbreviation: Prostate Cancer Prostatic Dis. Publication Date: 2004 |
Date Detail:
|
Created Date: 2004-12-13 Completed Date: 2005-03-29 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9815755 Medline TA: Prostate Cancer Prostatic Dis Country: England |
Other Details:
|
Languages: eng Pagination: 289-94 Citation Subset: IM |
Affiliation:
|
Urology and Transplantation Surgery, Edouard Herriot Medical Center, Claude-Bernard University, 5 Place d'Arsonval, 69437, Lyon Cedex, France. marc.colombel@chi-lyon.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Humans Male Prostatic Neoplasms / pathology, therapy* Ultrasound, High-Intensity Focused, Transrectal* / instrumentation, methods |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards.
Next Document: 5alpha-Androstane-3alpha,17beta-diol activates pathway that resembles the epidermal growth factor re...